In the end, 9 sites predicted to be associated with NSCLC were validated (Please see Supplementary Materials for more details), including one site located on the gene ING5) that shows no differential expression (log2 fold change = 0.07, FDR = 0.999) but significant differential methylation (log2 fold change = 0.762 and FDR = 0.027) (see Figure S3). The gene discussed is ING5; the disease is non-small cell lung carcinoma.